The Lachman Institute for Pharmaceutical Analysis is a fully renovated 2300 ft2 analytical laboratory equipped with advanced
analytical instrumentation in support of pre-clinical drug development research, industrial drug
development and compounding pharmacy activities.
The core capabilities for the Institute are focused on physical and chemical characterization including: solid state properties of APIs/excipients and dosage forms, chemical characteristics and chemical stability, degradant identification and quantitation, and changes during processing and storage.
Dr. Kenneth Morris is the Director of the Lachman Institute and a University Professor at Long Island University, Brooklyn. He is responsible for evaluating projects and working with stakeholders to design experiments and develop proposals with realistic timing and resource estimates. You are invited to contact Dr. Morris should you have projects that you feel fit into the Lachman Institute’s capabilities.
Projects at the Institute
Pre-clinical studies on small molecules in support of Quality by Design (QbD) and Question Based Reviews of new drug and ANDA applications
Development of analytical methods for Active Pharmaceutical Ingredients (APIs), Impurities, Dosage Forms, Dissolution, Form Selection, and Stability Studies
Beyond use dating and formulation development for compounding pharmacies
Investigating OOS (out of specification) results
Training for industrial, government, and academic scientists and regulators
Our instrumentation enables analysis in Five broad categories
Chemistry and solid state structural analyses (LC-MS, PXRD, Computational software)